29-May-2026
PRNewswire (Thu, 28-May 9:00 AM ET)
Globe Newswire (Wed, 27-May 7:47 PM ET)
Jefferies Sticks to Its Buy Rating for GeneDx Holdings (WGS)
TipRanks (Wed, 27-May 11:05 AM ET)
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Business Wire (Tue, 26-May 4:05 PM ET)
Small-cap healthcare stocks ranked by quant ratings after earnings season
Seeking Alpha News (Tue, 26-May 10:20 AM ET)
Globe Newswire (Wed, 20-May 9:30 AM ET)
GeneDx Holdings Corp. (WGS) Securities Fraud Investigation - Levi & Korsinsky
PRNewswire (Wed, 20-May 9:00 AM ET)
Globe Newswire (Tue, 19-May 6:22 PM ET)
Globe Newswire (Tue, 19-May 5:21 PM ET)
Levi & Korsinsky Announces Investigation of Securities Claims Against GeneDx Holdings Corp. (WGS)
Globe Newswire (Thu, 14-May 9:00 AM ET)
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Genedx Holdings Corp. - Class A trades on the NASDAQ stock market under the symbol WGS.
As of May 29, 2026, WGS stock price climbed to $51.99 with 1,109,229 million shares trading.
WGS has a beta of 1.04, meaning it tends to be more sensitive to market movements. WGS has a correlation of 0.02 to the broad based SPY ETF.
WGS has a market cap of $1.54 billion. This is considered a Small Cap stock.
Last quarter Genedx Holdings Corp. - Class A reported $102 million in Revenue and -$.28 earnings per share. This fell short of revenue expectation by $-10 million and missed earnings estimates by -$.25.
In the last 3 years, WGS traded as high as $170.87 and as low as $1.16.
The top ETF exchange traded funds that WGS belongs to (by Net Assets): ARKK, VTI, IWM, ARKG, VXF.
WGS has underperformed the market in the last year with a return of -25.7%, while the SPY ETF gained +29.5%. In the last 3 month period, WGS fell short of the market, returning -34.8%, while SPY returned +10.5%. However, in the most recent 2 weeks WGS has outperformed the stock market by returning +27.6%, while SPY returned +2.3%.
WGS support price is $47.32 and resistance is $52.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WGS shares will trade within this expected range on the day.